• Info
  • Significant Ownership

Significant Ownership of Sofinnova Venture Partners XI, L.P.

Signature - Title
/s/ Nathalie Auber - Nathalie Auber/Attorney-in-Fact
Location
Menlo Park, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Sofinnova Venture Partners XI, L.P..

Notify me when Sofinnova Venture Partners XI, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Sofinnova Venture Partners XI, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RAPP Rapport Therapeutics, Inc. Common Stock, $0.001 par value 4.2% $29,155,258 1,947,579 Dr. James I. Healy ("Healy") 11 Sep 2025

Schedules 13D/G Reported by Sofinnova Venture Partners XI, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.